vimarsana.com
Home
Live Updates
Professors Anna Schwedenman¹ and Sarfaraz Niazi² a
Professors Anna Schwedenman¹ and Sarfaraz Niazi² a
Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars
CHICAGO, Nov. 22, 2022 /PRNewswire/ -- To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity,
Related Keywords
Michigan ,
United States ,
University Of Illinois ,
Illinois ,
Chicago ,
J Clin Pharm ,
Us Senate ,
College Of Pharmacy ,
Us Congress ,
University Of Michigan ,
Analytical Characterization ,
Biosimilar Products ,
Post Translational Modifications ,
Professors Schwendeman ,
Waiving Clinical Efficacy Testing ,
Drug Des Devel ,
Clin Pharm ,
Sarfaraz Niazi Convinces ,